KRAS G12C Mutant Solid Tumors

Explore clinical trials studying KRAS G12C Mutant Solid Tumors. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

KRAS G12C Mutant Solid Tumors trial results

Active, Not Recruiting

NCT05358249

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

NYU School of Medicine New York, United States

Novartis Investigative Site Leuven, Belgium

View all 13 locations

Active, Not Recruiting

NCT04699188

Conditions: Bronchial Neoplasms, Cancer of Lung, Cancer of the Lung, +29 more
Locations: Emory University School of Medicine-Winship Cancer Institute Atlanta, Georgia, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View all 38 locations